Puzzling over MDM4-p53 network

被引:23
|
作者
Mancini, F. [1 ,2 ]
Di Conza, G. [1 ,3 ]
Monti, O. [1 ,2 ]
Macchiarulo, A. [4 ]
Pellicciari, R. [4 ]
Pontecorvi, A. [2 ]
Moretti, F. [1 ]
机构
[1] CNR, Inst Neurobiol & Mol Med, Fdn Santa Lucia, I-00143 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Div Endocrinol, Rome, Italy
[3] Univ Messina, Dept Expt Clin Med & Pharmacol, I-98100 Messina, Italy
[4] Univ Perugia, Dept Chem & Technol Drugs, Fac Pharm, I-06100 Perugia, Italy
关键词
MDM4 (MDMX); p53; MDM2; DNA damage; cancer; P53 TRANSCRIPTIONAL PATHWAYS; INTRINSIC-APOPTOTIC PATHWAY; DNA-DAMAGE; MDMX; PHOSPHORYLATION; CANCER; ACTIVATION; PROTEIN; ATM; DEGRADATION;
D O I
10.1016/j.biocel.2010.04.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MDM4 (also called MDMX) has been initially identified as p53 inhibitor. Subsequent data have reinforced this role pointing to the requirement for MDM4 repressive activity on p53 for mouse embryo development. Molecular studies have shown that MDM4 exerts different activities by controlling both p53 transcriptional function and protein levels. On the basis of these data, therapeutic strategies aiming at releasing p53 from MDM4 inhibition are under development. However, recent studies suggest a more complex relationship between MDM4 and p53. These have evidenced heterogeneity of MDM4 function under different growth conditions and particularly positive activity exerted by MDM4 on stress-activated p53 levels and pro-apoptotic function. This review summarizes the different facets of MDM4-mediated regulation of p53 and the modifications able to modulate MDM4 localization and function. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1080 / 1083
页数:4
相关论文
共 50 条
  • [21] Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    Pant, Vinod
    Xiong, Shunbin
    Iwakuma, Tomoo
    Quintas-Cardama, Alfonso
    Lozano, Guillermina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 11995 - 12000
  • [22] Selective and dual action p53/mdm2/mdm4 antagonists
    Wang, Kan
    Doemling, Alexander
    CANCER RESEARCH, 2009, 69
  • [23] The Regulation of the p53-mediated Stress Response by MDM2 and MDM4
    Perry, Mary Ellen
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (01): : a000968
  • [24] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [25] MDM2 and MDM4: p53 regulators as targets in anticancer therapy
    Toledo, Franck
    Wahl, Geoffrey M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8): : 1476 - 1482
  • [26] Mdm2 and Mdm4 loss regulates distinct p53 activities
    Barboza, Juan A.
    Iwakuma, Tomoo
    Terzian, Tamara
    El-Naggar, Adel K.
    Lozano, Guillermina
    MOLECULAR CANCER RESEARCH, 2008, 6 (06) : 947 - 954
  • [27] Disrupting p53:Mdm2 and p53:Mdm4-Comparative cell-based assays for drug screening
    Yurlova, Larisa
    Brown, Christopher J.
    Derks, Maarten
    Ghadessy, Farid John
    Hickson, Ian
    Lane, David P.
    Krausz, Eberhard
    Zolghadr, Kourosh
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review
    Teveroni, Emanuela
    Luca, Rossella
    Pellegrino, Marsha
    Ciolli, Germana
    Pontecorvi, Alfredo
    Moretti, Fabiola
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (12) : 1417 - 1429
  • [29] Mdm4 regulates mutant p53 stability in vivo
    Plehaty, Molly
    Srinivas, Tara
    Stevens, Wanida
    Sobhani, Nema
    Iwakuma, Tomoo
    Podell, Brendan
    Arbab, Farinaz
    Terzian, Tamara
    CANCER RESEARCH, 2017, 77
  • [30] Targeting MDM4 to reactivate p53 signaling in neuroblastoma
    Chen, Zhenghu
    Woodfield, Sarah E.
    Patel, Roma H.
    Ibarra, Aryana M.
    Vasudevan, Sanjeev A.
    CANCER RESEARCH, 2019, 79 (13)